Neuro.Al Algorithm

The Neuro.AI Algorithm is an advanced image processing software designed to assist clinicians by analyzing CT and MRI brain scans for detailed perfusion characteristics, including motion correction and calculation of multiple hemodynamic parameters. Utilizing methodologies such as parametric mapping and rotational MIP displays, it provides quantitative and visual data, validated through performance testing, to support diagnostic decision-making in neurological assessments, delivering results in DICOM format for broad compatibility.

The Neuro.AI Algorithm is a standalone image processing software designed for trained medical professionals to aid in the diagnosis of brain conditions. It processes static, functional, dynamic, and derived imaging datasets acquired from CT or MRI scans to analyze brain perfusion, incorporating motion correction and calculating key hemodynamic parameters such as time to peak (TTP), mean transit time (MTT), blood volume (BV/CBV), and blood flow (BF/CBF). The software generates outputs including parametric maps, classification maps, and reformatted images, with options to include or exclude brain ventricles in calculations, alongside vascular assessment through rotational Maximum Intensity Projections (MIP), known as the "tumble view," providing a comprehensive analytical view of brain tissue perfusion and vascular structures. The Neuro.AI Algorithm delivers its analytical outputs, validated through performance testing to meet its specified requirements, in DICOM format. These results, encompassing text and parametric map displays, can be viewed on various systems like TeraRecon's iNtuition or Northstar AI Results Explorer, as well as third-party PACS, facilitating 2D and 3D visualization. Deployable as a Microsoft Windows executable or a containerized application on standard hardware or cloud platforms, it utilizes methods like Singular Value Decomposition (SVD) for mathematical modeling. The algorithm is intended as a supporting tool to enhance diagnostic workflows and communication for physicians, who retain ultimate responsibility for clinical decisions.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the algorithm's performance in motion correction compare across different levels of patient movement during CT/MRI acquisition?; What is the quantitative impact of including versus excluding brain ventricles in perfusion calculations on diagnostic accuracy for specific neurological conditions?; Can the "tumble view" (rotational MIP) feature be customized for different vascular territories or specific clinical queries, and what is its added diagnostic value over standard MIP?; How does the Neuro.AI Algorithm's performance (e.g., accuracy of TTP, MTT, CBF, CBV) compare when processing data from different CT/MRI scanner vendors and models?; What are the specific image quality prerequisites (e.g., slice thickness, contrast injection protocol) for optimal performance of the Neuro.AI algorithm in generating reliable perfusion maps?